HIV care providers and researchers applaud release of national HIV/AIDS strategy

July 13, 2010

The HIV Medicine Association applauds the Obama administration's release of a National HIV/AIDS Strategy that signals a strengthened national commitment to real and sustained success in the battle against HIV/AIDS. As clinicians and researchers on the frontline of this pandemic, we welcome this new comprehensive roadmap and look forward to working with diverse stakeholders at all levels of government and within the private sector to implement it. The success of the initiative will depend on an effective implementation plan supported by the resources necessary for monitoring and evaluation and to meet the strategy's stated targets. With resources and a robust implementation plan, we can realize the strategy's call for a nation in which new HIV infections are dramatically reduced, and those who are infected have prompt access to the comprehensive quality care and treatment they need, without fear of stigma or discrimination.

Ensuring that people with HIV disease are diagnosed early and linked to lifesaving medical care is central to the president's strategy. A renewed focus on patient care is urgently needed to meet the increased demand for HIV care, which will grow under this effort. Funding for clinics that provide HIV care to low-income or uninsured patients, and support for an adequate and diverse HIV medical workforce, are urgently needed to ensure the care system has the capacity to fulfill these important goals. We are excited about the launching of this long-awaited initiative, and look forward to partnering on its implementation to make the strategy's vision a reality.

Statement from Kevin Carmichael, MD, co-chair of Ryan White Medical Providers Coalition (RWMPC)

As providers of lifesaving, comprehensive medical care to people infected with HIV across the country, the Ryan White Medical Providers Coalition welcomes the release of the National HIV/AIDS Strategy, which provides an important HIV policy roadmap for our nation. We applaud the administration's commitment to develop this coordinated approach and hope this impressive level of commitment will be sustained in the implementation phase.

Reducing HIV incidence, increasing access to care, improving health outcomes, and reducing HIV-related disparities--the strategy's core goals--will require everyone's help to achieve, and we look forward to working with federal partners and other stakeholders to advance these goals, which we hope will be supported by the necessary funding and additional resources to meet the increasing demand for HIV care. As providers of quality HIV care to low-income or uninsured patients at clinics funded through Part C of the Ryan White program, we experience firsthand the challenges of delivering this complex but lifesaving treatment to more and more patients while funding fails to keep pace. Federal funding for these clinics has grown just 9 percent since 2001, while the number of patients who rely on these clinics has increased 59 percent.

The unveiling of the National HIV/AIDS Strategy marks an important and eagerly awaited step. For the sake of our patients, we hope adequate resources are dedicated to help achieve this important new initiative's goals, and welcome opportunities to support a robust implementation plan that ultimately will determine its success.
-end-
The HIV Medicine Association (HIVMA) is the professional home for more than 3,800 physicians, scientists and other health care professionals dedicated to the field of HIV/AIDS. Nested within the Infectious Diseases Society of America (IDSA), HIVMA promotes quality in HIV care and advocates policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. IDSA is a professional society representing more than 9,000 physicians and scientists who specialize in infectious diseases. For more information, visit our websites: www.hivma.org and www.idsociety.org.

The Ryan White Medical Providers Coalition (RWMPC) was formed in 2006 to be a voice for medical providers across the nation delivering quality care to their patients through Part C of the Ryan White program. Ryan White Part C funds comprehensive HIV care and treatment-the services that are directly responsible for the dramatic decreases in AIDS-related mortality and morbidity over the last decade. We speak for those who often cannot speak for themselves, and we advocate for a full range of primary care services for this unique population. We have a broad and diverse membership that represents highly qualified medical professionals and administrators who are Part C grantees across the nation. RWMPC is sponsored by HIVMA.

Infectious Diseases Society of America

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.